MATTHEW PERRY

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Thomas Burns, Authorized Signatory for Matthew Perry
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by MATTHEW PERRY:

Company Role Class Num Shares Value Price $ Report Date Ownership
XOMA Royalty Corp Director Common Stock 23,840 $586,702 $24.61 21 May 2025 Direct
CTI BIOPHARMA CORP Director Common Stock 0 $9.10 26 Jun 2023 Direct
CTI BIOPHARMA CORP Director Stock Option (Right to Buy) 0 26 Jun 2023 Direct

Insider Reports Filed by MATTHEW PERRY

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XOMA XOMA Royalty Corp 21 May 2025 1 $0 4 Director 23 May 2025, 16:47
XOMA XOMA Corp 15 May 2024 1 $0 4 Director, Other* 17 May 2024, 16:30
CTIC CTI BIOPHARMA CORP 26 Jun 2023 7 $-392,565 4 Director 26 Jun 2023, 16:05
XOMA XOMA Corp 17 May 2023 1 $0 4 Director, Other* 19 May 2023, 16:30
CTIC CTI BIOPHARMA CORP 05 Apr 2023 1 $0 4 Director 07 Apr 2023, 18:16
XOMA XOMA Corp 18 May 2022 1 $0 4 Director 20 May 2022, 09:00
CTIC CTI BIOPHARMA CORP 09 Mar 2022 1 $0 4 Director 11 Mar 2022, 18:46
XOMA XOMA Corp 19 May 2021 1 $0 4 Director, Other* 21 May 2021, 18:47